NEO - NeoGenomics Inc Stock Price & Dividend Safety Sector: Healthcare | Exchange: NASDAQ Capital Market Current Price & Safety Score Price: 17.27 USD StockBonds Safety Grade: F Altman Z-Score (Bankruptcy Risk): 2.52 StockBond Score: -1.53 Company Description NeoGenomics Inc specializes in providing cancerfocused diagnostic and testing services through an extensive network of laboratories located across the United States Europe and Asia The company operates through two distinct divisions Clinical Services and Pharma Services Its comprehensive offerings cater to a diverse clientele including hospitals reference laboratories pathologists oncologists clinicians pharmaceutical companies and researchers NeoGenomics advanced testing capabilities encompass cytogenetics which examines normal and abnormal chromosomes in relation to disease fluorescence insitu hybridization FISH for detecting and pinpointing specific DNA sequences and genes on chromosomes and flow cytometry used to measure cell population characteristics Additionally the company provides immunohistochemistry and digital imaging services enabling the localization of cellular proteins in tissue sections visualization of scanned slides and quantitative analysis Molecular testing focusing on DNARNA analysis and gene structurefunction is also a key offering alongside morphologic analysis where pathologists microscopically diagnose cells Beyond clinical diagnostics NeoGenomics supports pharmaceutical clients oncology programs from discovery to commercialization and acts as a reference laboratory for anatomic pathology testing The company founded in 2001 and headquartered in Fort Myers Florida also maintains a strategic alliance and laboratory services agreement with Inivata Limited